Capital International Investors
KRON

Capital International Investors’s Kronos Bio KRON Stock Holding History

Capital International Investors’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-600,000
Closed -$8.15M – 467
2021
Q4 		$8.15M Hold
600,000
– – ﹤0.01% 431
2021
Q3 		$12.6M Hold
600,000
– – ﹤0.01% 419
2021
Q2 		$14.4M Hold
600,000
– – ﹤0.01% 417
2021
Q1 		$17.6M Hold
600,000
– – ﹤0.01% 396
2020
Q4 		$17.9M Buy
+600,000
New +$18.8M ﹤0.01% 389

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Capital International Investors's KRON Position: Q1 2022 in Review

Capital International Investors sold out of Kronos Bio (KRON) in Q1 2022, closing a stake of 600,000 shares — an estimated $8.15M sold.

Capital International Investors first reported a position in KRON in Q4 2020 and held it in 5 quarters. The position peaked at $17.9M in Q4 2020. 96 funds tracked by Wall St. Rank hold KRON as of Q1 2022.

  • Capital International Investors reported no remaining Kronos Bio position as of Q1 2022 after selling out during the quarter.
  • Capital International Investors sold 600,000 Kronos Bio shares in Q1 2022, an estimated $8.15M.
  • Capital International Investors first reported a position in Kronos Bio in Q4 2020 and held it in 5 quarters.
  • Capital International Investors's Kronos Bio position peaked at $17.9M in Q4 2020.
  • 96 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2022.

Based on Capital International Investors's 13F filing for Q1 2022, filed 16 May 2022.